Date: February 26, 2026
Time: 1:00pm EST
Register Now
Perfusion programs face high expectations for safety, oversight, and efficiency. Central to these responsibilities is the documentation of cell salvage device performance and ensuring the quality of reinfused blood.
On February 26th, join Dr. Tim Maul of Nemours Children’s Health for an educational webinar exploring the clinical and operational aspects of hemolysis monitoring. This session will move beyond non-specific biomarkers to examine how quantitative data can strengthen program quality.
Key Learning Objectives:
- Understanding the clinical significance of hemolysis: How mechanical stress causes red cell damage and the resulting link between elevated plasma free hemoglobin and patient complications.
- Evaluating current methods and potential gaps: Why direct plasma free hemoglobin offers a more specific indication of red cell destruction than indirect markers like lactate dehydrogenase.
- Review quality standards: Discuss AABB recommendations for robust QC programs and the use of reproducible data for performance benchmarking.
Learn how perfusionists can lead the shift toward more specific, reliable hemolysis assessment to improve overall program oversight.
Speaker
Back to All Events